Genetic Technologies Cash Flow From Operations vs. Revenue
| GTG Stock | 0.04 0.00 0.00% |
For Genetic Technologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Genetic Technologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Genetic Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Genetic Technologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Genetic Technologies over time as well as its relative position and ranking within its peers.
Genetic |
Genetic Technologies Revenue vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Genetic Technologies's current stock value. Our valuation model uses many indicators to compare Genetic Technologies value to that of its competitors to determine the firm's financial worth. Genetic Technologies is one of the top stocks in cash flow from operations category among its peers. It also is rated as one of the top companies in revenue category among its peers . At this time, Genetic Technologies' Total Revenue is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genetic Technologies' earnings, one of the primary drivers of an investment's value.Genetic Revenue vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Genetic Technologies |
| = | (9.68 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Genetic Technologies |
| = | 7.66 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Genetic Revenue vs Competition
Genetic Technologies is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 3.01 Billion. Genetic Technologies adds roughly 7.66 Million in revenue claiming only tiny portion of equities under Health Care industry.
Genetic Technologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Genetic Technologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Genetic Technologies will eventually generate negative long term returns. The profitability progress is the general direction of Genetic Technologies' change in net profit over the period of time. It can combine multiple indicators of Genetic Technologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.4 M | 4.3 M | |
| Operating Income | -6.5 M | -6.9 M | |
| Income Before Tax | -12 M | -11.4 M | |
| Total Other Income Expense Net | -5.5 M | -5.2 M | |
| Net Loss | -12 M | -11.4 M | |
| Income Tax Expense | -2 M | -1.9 M | |
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -12 M | -12.6 M | |
| Net Interest Income | -323.7 K | -307.6 K | |
| Interest Income | 119.5 K | 72.6 K | |
| Change To Netincome | 2 M | 2.1 M |
Genetic Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Genetic Technologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Genetic Technologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Genetic Technologies' important profitability drivers and their relationship over time.
Use Genetic Technologies in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genetic Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genetic Technologies will appreciate offsetting losses from the drop in the long position's value.Genetic Technologies Pair Trading
Genetic Technologies Pair Trading Analysis
The ability to find closely correlated positions to Genetic Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genetic Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genetic Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genetic Technologies to buy it.
The correlation of Genetic Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genetic Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genetic Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genetic Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Genetic Technologies position
In addition to having Genetic Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities ETFs Thematic Idea Now
Utilities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.